PAA 2.56% 20.0¢ pharmaust limited

Clinical Trials, page-253

  1. 199 Posts.
    lightbulb Created with Sketch. 94
    Not usually one to upramp much, but come on, PAA has 1: a possible (likely even) upcoming deal with Vet major on successful phase 2 canine trial for cancer, the proceeds of which could fund 2: phase 2 human trials (for potentially multiple cancers!!!) and in the meantime, 3: the likelihood of human trials for Covid 19 with 95% effectiveness against virus, and who knows what other viruses in future through the cutting edge mTor inhibitor. Make it in one of these and we're off- imagine a commercial deal in all 3- bang bang bang. And don't forget Epichem, which is quietly expanding and seeking out new contracts. Does it get better than this? not in my VERY limited experience. I still shake my head at the potential calculations here- as if im missing something. Early days, dyor
    Last edited by ArtistPete: 03/07/20
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.005(2.56%)
Mkt cap ! $97.22M
Open High Low Value Volume
19.5¢ 20.0¢ 19.5¢ $199.9K 1.004M

Buyers (Bids)

No. Vol. Price($)
8 457971 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 1207 1
View Market Depth
Last trade - 16.10pm 30/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.